Coverage
-
September 09, 2019
Taiwan's JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of an unfinalized deal to end high-stakes trade secrets litigation, Genentech confirmed Monday.
2 other articles on this case.
View all »